Pfizer Rebuffed by AstraZeneca, Regroups

April 22, 2014 | Talks between Pfizer and AstraZeneca fizzled, but the possibility foretells future big deals, says Bloomberg. Some analysts expect Pfizer to approach AstraZeneca again soon, while others expect a merger between AstraZeneca and another peer-sized pharma like Amgen. If AZ continues to decline Pfizer's offer, the world's biggest drugmaker may have backup plans. Bloomberg